0001156039-23-000031.txt : 20230303
0001156039-23-000031.hdr.sgml : 20230303
20230303162801
ACCESSION NUMBER: 0001156039-23-000031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Penczek Ronald W
CENTRAL INDEX KEY: 0001659075
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16751
FILM NUMBER: 23704511
MAIL ADDRESS:
STREET 1: 120 MONUMENT CIRCLE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elevance Health, Inc.
CENTRAL INDEX KEY: 0001156039
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 352145715
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 220 VIRGINIA AVENUE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204
BUSINESS PHONE: 8003311476
MAIL ADDRESS:
STREET 1: 220 VIRGINIA AVENUE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204
FORMER COMPANY:
FORMER CONFORMED NAME: Anthem, Inc.
DATE OF NAME CHANGE: 20141202
FORMER COMPANY:
FORMER CONFORMED NAME: WELLPOINT, INC
DATE OF NAME CHANGE: 20100105
FORMER COMPANY:
FORMER CONFORMED NAME: WELLPOINT INC
DATE OF NAME CHANGE: 20041130
4
1
wf-form4_167787883238771.xml
FORM 4
X0306
4
2023-03-01
0
0001156039
Elevance Health, Inc.
ELV
0001659075
Penczek Ronald W
220 VIRGINIA AVENUE
INDIANAPOLIS
IN
46204
0
1
0
0
CAO & Controller
Common Stock
2023-03-01
4
F
0
64
469.03
D
1853
D
Common Stock
2023-03-01
4
A
0
214
0
A
2067
D
Common Stock
2023-03-01
4
A
0
1195
0
A
3262
D
Common Stock
2023-03-02
4
F
0
380
468.78
D
2882
D
Employee Stock Option (Right to Buy)
469.03
2023-03-01
4
A
0
819
0
A
2033-03-01
Common Stock
819.0
819
D
PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Represents restricted share units. Restrictions lapse as follows: 71 shares each on 3/1/2024 and 3/1/2025 and 72 shares on 3/1/2026.
Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
Balance includes 3.60 shares acquired on March 25, 2022, 3.67 shares acquired on June 24, 2022, 3.80 shares acquired on September 23, 2022 and 3.46 shares acquired on December 21, 2022 through a dividend reinvestment plan.
The option represents a right to purchase a total of 819 shares, and is exercisable in three installments of 273 shares each, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.
/s/ Kathleen S. Kiefer, Attorney in fact
2023-03-03